15-PGDH regulated PD-1/PD-L1 immune checkpoint blockade immunotherapy in colon cancer is a TNF-alpha dependent phenomenon. Satapathy S, Sjolander A. Ann Oncol 2019;30 Suppl 4:iv107.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Satapathy S, Sjolander A. 15-PGDH regulated PD-1/PD-L1 immune checkpoint blockade immunotherapy in colon cancer is a TNF-alpha dependent phenomenon. Ann Oncol 2019;30 Suppl 4:iv107.
PMID: 32084956